Update: Peaked 100% from Recommended Price | Incredible | Subscribe Premium Service for Super Multibaggers & Real Investor Secrets
In this post we can explore Thyrocare Technologies as a Multibagger in Warren Buffet way in Indian Stock Market. (Full Report is available to Subscribers)
Thyrocare Technologies
| NSE Code | THYROCARE.NS |
| BSE Code | 539871 |
| URL | http://www.thyrocare.com/ |
| CMP | 525.00 |
| Free Report | Yes |
| Publish Date | May-9-2020 |
About Company
Thyrocare is India’s first fully automated diagnostic laboratory with a focus on providing quality at affordable costs to laboratories and hospitals in India and other countries.
Thyrocare operates with a Centralized Processing Laboratory (CPL) in Mumbai – India for esoteric tests; and Regional Processing Laboratory in major metro cities of India and other parts of Asia. We have focus on strong technologies, strong brands and strong systems that enable all laboratories to give their clients the best of science and technology at an affordable cost.
Warren Buffet, Value & Growth Checklist
Following are the Checklist parameters:
| Capitalization | 2700CR – Can provide good amount of growth to reach 100K Capitalization |  |
| History of Consistently Increasing Sales, Earnings & Cash Flow | Yes. | |
| Durable Competitive Advantage | Moderate |  |
| Future Growth Drivers / Sector Growth | Moderate | |
| Conservative Debt (long term debt < 3 Net Profit) | Low Debts | |
| Debt Equity Ratio, Current Ratio | Low Debt
Current Ratio is 3 |
|
| Return on Equity must be Above Average | 20% | |
| Low CAPEX required to maintain current operations | Moderate | |
| Inventory Turnover Ratio, Debtor Days, ROCE | Good | |
| Management is holding / buying the stock | Promoter holding is at 66% & Increasing | |
| Market Price < Intrinsic Value | Only at 10% Discount
|
 |
| Stock Price is consolidating (now) | Yes | |
| Stock Price is growing in past years along with EPS growth | No, North-South curves exists | |
| Consolidated PE, PB Ratio, PEG Ratio | PE 23 (High)
PB 8 (Very High) PEG 1.6 (High) |
|
| Cash Flow Positive, Net Profit % greater than 8% | Cash Flow: Okay
Profit %: 20% |
|
| Paying Dividends, Tax | Yes DividendsYes Tax | |
| EPS Growth Rate | 12% above past 2 years | |
| Jump in Trailing Result EPS | Yes | |
| Jump in Quarterly Result EPS | Yes | |
| Expected Gain in 5 Years | 300-500% | |
| Price Movement Graph, 52 Week High & Low | Okay | |
| Volume Analysis | 92 Thousand | |
| Power of Brand | Moderate | |
| Corporate Governance, Reputation of Leaders | Okay | |
| Fraud reported | No. | |
Positive Factors
Here are the positive factors regarding Thyrocare Technologies
- Company is having Steady EPS Growth
- Company have Low debts
- Corona Issue is Accelerating Growth of Company
Concern Factors
Here are the concern factors regarding Thyrocare Technologies
- Valuation is High due to PE & PB
- Margin of Safety is Low – One has to Ensure Current Corona Impacts increases Sales
Summary
Based on the above analysis I would like to say that the Thyrocare Technologies possess Multibagger Stock properties and one can Invest in 2020. However one should not expect high compounded returns from this stock. It can be considered as Moderate Risk Moderate Returns investment.
FREE Multibagger India 2023
Multibagger with Expansion Plans | Low PE Ratio | Low Book Value Ratio | Intrinsic Value Discount 70 % | PLUS Free Value Investing Education